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Abstract
Objective: This study sought to investigate whether the immediate systemic inflam-
matory response following full-mouth debridement differs following use of hand 
compared with ultrasonic instruments.
Methods: Thirty-nine periodontitis patients were randomized to treatment with 
full-mouth debridement using either hand or ultrasonic instrumentation completed 
within 24 hr. Serum and periodontal clinical parameters were collected at baseline, 
day 1, day 7 and day 90 post-treatment. Differences in systemic inflammatory mark-
ers were assessed using general linear models at each timepoint, corrected for age, 
gender, smoking status, body mass index and baseline levels of each marker.
Results: Across all patients, serum C-reactive protein increased at day 1, with no dif-
ferences between hand and ultrasonic groups (p(adjusted) = .22). There was no dif-
ference between groups in interleukin-6 (p(adjusted) = .29) or tumour necrosis factor 
α (p(adjusted) = .53) at day 1. Inflammatory markers returned to baseline levels by 
day 7. Treatment resulted in equal and marked improvements in clinical parameters 
in both groups; however, total treatment time was on average shorter for ultrasonic 
instruments (p(adjusted) = .002).
Conclusions: Ultrasonic instrumentation resulted in shorter treatment time with 
comparable clinical outcomes. Levels of serum C-reactive protein at day 1 were simi-
lar following debridement with hand or ultrasonic instruments.
K E Y W O R D S
hand instruments, periodontal treatment, randomized controlled trial, systemic inflammation, 
ultrasonic instruments
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1  | INTRODUC TION
Periodontitis (PD) affects 20%–50% of the total global popula-
tion, with severe disease occurring in 9.8% of individuals (Albandar 
& Rams, 2002; Bernabe et al., 2020). For the majority of patients, 
non-surgical periodontal treatment (NSPT) represents the first line 
of treatment and involves the physical debridement of subgingival 
plaque biofilms. There is significant evidence of clinical improve-
ments in PD patients following NSPT, including gains in clinical at-
tachment level, reductions in gingival inflammation and reduced 
periodontal pocket depths (Graziani et al., 2010; Heitz-Mayfield, 
Trombelli, Heitz, Needleman, & Moles, 2003; Suvan et al., 2019).
Non-surgical periodontal treatment may be carried out with hand 
instruments, ultrasonic instruments or a “blended approach” using 
both. Similarly, treatment may be staged over several visits with a 
“quadrant” approach, or with a “full-mouth debridement” approach, 
also referred to as an “intensive treatment” approach, that delivers 
complete debridement within 24 hr. Although the clinical outcomes 
for quadrant and full-mouth treatment appear similar, there is a 
measurable difference in the inflammatory response following full-
mouth compared with quadrant debridement (Graziani et al., 2015). 
Intensive/full-mouth NSPT has been consistently shown to trigger 
a larger systemic inflammatory response, demonstrated by signifi-
cant increases in serum levels of C-reactive protein (CRP), interleu-
kin-6 (IL-6) and tumour necrosis factor alpha (TNFα) 24 hr following 
treatment (Graziani et al., 2015; Morozumi et al., 2018; Tonetti et al., 
2007). Whilst this increase in systemic inflammation is short lived 
and typically resolves within 7 days (Graziani et al., 2015; Graziani 
et al., 2010; Tonetti et al., 2007), a recent joint consensus statement 
advised against full-mouth debridement for some medically compro-
mised patients (Sanz et al., 2020).
Studies investigating the systemic inflammatory response gen-
erally report use of both hand and ultrasonic instruments in combi-
nation. When used individually, both types of instrument have been 
shown to significantly improve the clinical status of patients with 
equal efficacy (Ioannou et al., 2009; Suvan et al., 2019). Although 
the clinical outcomes are similar, several studies report lower treat-
ment times using ultrasonic instruments in comparison with hand 
instruments (Copulos, Low, Walker, Trebilcock, & Hefti, 1993; 
Dragoo, 1992; Tunkel, Heinecke, & Flemmig, 2002; Yukna, Scott, 
Aichelmann-Reidy, LeBlanc, & Mayer, 1997). Interestingly, a positive 
correlation between treatment time and CRP levels 24 hr after treat-
ment has been reported (Graziani et al., 2015).
Given this previous link between treatment time and the subse-
quent systemic inflammatory response, and the different features 
of each instrumentation technique including delivery of water ir-
rigation and the reduction in cementum removal with ultrasonics 
(Bozbay et al., 2018; Ruhling, Bernhardt, & Kocher, 2005), we hy-
pothesized that hand and ultrasonic instruments may differ in the 
extent of systemic inflammation they induce. Thus, the aim of this 
study was to investigate changes in systemic markers of inflamma-
tion 24 hr following full-mouth debridement, comparing hand in-
strumentation (HI) and ultrasonic instrumentation (UI). Secondary 
outcomes included comparing clinical parameters and treatment 
time between each group.
2  | METHODS
2.1 | Study design and patient selection
This was a single-centre randomized controlled trial with two inter-
vention arms, with patients returning at day 1, day 7 and day 90 post-
treatment. The study received approval from the Research Ethics 
Committee (18/NI/0059) and was registered with ClinicalTrials.gov 
(ID: NCT03501316). The principles in the Declaration of Helsinki 
were adhered to throughout the trial.
Patients were referred by their General Dental Practitioner (GDP) 
to Unit of Periodontics at Glasgow Dental Hospital for specialist man-
agement of periodontal disease. The specialist service is provided by 
the National Health Service, and prior to referral patients attend their 
GDP for assessment and initial periodontal treatment including oral 
hygiene instruction. Patients were approached during new patient 
assessment clinics in the Unit of Periodontics. All participants gave 
informed, written consent. The inclusion criteria were as follows: male 
or female patients aged 18–70 years inclusive with probing depths 
≥5 mm on two or more teeth at non-adjacent sites with cumulative 
probing depths of ≥40 mm. Cumulative probing depth was calculated 
by examining six sites on each tooth. The deepest site on each tooth 
was recorded and if the value was >4 mm, this contributed to the 
cumulative total, with each tooth being only counted once towards 
the total to ensure extent of disease. The use of cumulative probing 
pocket depth ensured a minimum level of periodontal disease (≥2 sites 
with probing depths with ≥5 mm) (Page & Eke, 2007; Tonetti & Claffey, 
2005) and has recently been adopted as a means of including patients 
Clinical Relevance
Scientific rationale for the study: Intensive full-mouth de-
bridement has been consistently demonstrated to induce 
a systemic inflammatory response 24 hr after treatment, 
which has previously been linked to duration of treatment. 
In medically compromised patients, this inflammatory re-
sponse is hypothesized to potentially aggravate pre-exist-
ing conditions.
Principle findings: We have demonstrated that this sys-
temic inflammatory response is comparable following full-
mouth debridement with hand or ultrasonic instruments, 
with faster treatment time with ultrasonic instruments. 
Improvements in clinical outcomes were comparable be-
tween groups.
Practical implications: The choice of hand or ultrasonic in-
struments does not appear to impact the systemic inflam-
matory response 1 day following full-mouth debridement.
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with a disease burden that is potentially relevant to systemic inflam-
mation (Lopez-Oliva Santa Cruz 2018; Serban et al., 2019). Exclusion 
criteria included the following: known or suspected high risk for tu-
berculosis, hepatitis B or HIV infections; required interpreter/non-En-
glish language written material to understand and provide written, 
informed consent or any other reason for being unable to provide 
written, informed consent; history of bleeding diathesis; pregnant or 
lactating females; self-reported diagnosis of any systemic illnesses in-
cluding cardiovascular, renal and liver diseases, and/or regular use of 
medication to control systemic illness; any pharmacological treatment 
within 1 month before the beginning of the study, including routine 
use of any over the counter medications and specialist periodontal 
treatment in the previous 6 months.
All visits were carried out within the clinical research facility of 
the Glasgow Dental Hospital. Baseline data were gathered including 
height, weight, blood pressure (using an automatic oscillometric unit) 
and smoking status was recorded as “never,” “current” or “previous.” 
Samples taken at baseline included serum, whole blood, saliva, sub-
gingival plaque and gingival crevicular fluid.
2.2 | Study procedures
At the baseline visit, patients were provided with detailed oral hygiene 
instruction, dental health education and a full-mouth supragingival 
scale (using a Cavitron® Powerline® 1000 30K insert). All interven-
tions and clinical data collection were carried out by an experienced 
dental hygienist (DM) and specialist trainee in restorative dentistry 
(MP). For calibration, both examiners completed pocket charts on 
the first twelve patients entering the study. Charts were assessed for 
agreement and a kappa score was calculated (0.66). Following collec-
tion of blood samples at day 1 post-treatment, patients were provided 
with an electric toothbrush (Oral-B Pro 2000) to standardize self-per-
formed plaque control prior to day 90 follow-up.
At baseline and day 90, clinical parameters (full-mouth plaque, 
bleeding scores and detailed 6-point periodontal pocket charting) 
were assessed using a PCP-12 periodontal probe at six sites per 
tooth, excluding third molars (unless other molar units missing), with 
measurements rounded to the nearest millimetre. Following collec-
tion of clinical data, the periodontal inflamed surface area (PISA) was 
calculated as previously described (Nesse et al., 2008).
Patients were randomized to one of two treatments (HI or UI) 
(Figure 1). Randomization was performed using a computerized ran-
dom number generator (using permuted blocks of 4 and 6). Patients 
were stratified according to smoking status prior to randomization.
For allocation concealment and blinding, patients were allocated to 
each arm of the study by a member of the research team not involved 
with the clinical delivery of the experimental interventions. Upon at-
tending their treatment appointment, an opaque sequentially numbered 
envelope contained the allocated intervention arm for the patient. This 
was opened immediately before treatment was commenced.
Patients and clinicians both remained blinded to the interven-
tion until the intervention visit. Statistical and laboratory personnel 
remained blinded to specific patient allocation throughout the entire 
process via patient barcodes. The key linking barcodes to patients 
was available only to the chief investigator. Intervention codes were 
only available once all analyses took place.
Full-mouth debridement was carried out within a 24-hr period. 
All but one patient completed treatment within the same day; a 
single patient completed debridement on consecutive days, within 
24 hr, due to patient availability. Debridement was completed using 
Gracey and Universal curettes (Gracey 1/2, Gracey 7/8, Gracey 
9/10, Gracey 11/12, Gracey 13/14, Columbia 4L-4R) and hoes (Hoe 
Scaler-lateral, Hoe Scaler-posterior, LM Dental) for the hand in-
strumentation (HI) group; or Cavitron Ultrasonic inserts (Cavitron® 
Thinsert® 30K, Cavitron® Slimline® 10S 30K, Cavitron® Slimline® 
10L 30K, Cavitron® Slimline® 10R 30K, Cavitron® Slimline® 1000 
30K, Cavitron® Powerline® 1000 30K; Dentsply Sirona) for the ul-
trasonic instrumentation (UI) group. Treatment was provided using 
local anaesthetic and timed by digital stopwatch from the point of 
first contact between instrument and tooth surface. Debridement 
was carried out until no supra or subgingival plaque or calculus de-
posits were detectable by visual examination with magnification or 
by tactile examination. Patients were recalled following periodontal 
treatment at day 1, day 7 and day 90. Samples were collected as per 
baseline visit (serum, whole blood, saliva, subgingival plaque, GCF) 
at each timepoint, with clinical parameters measured at day 90 only. 
Following day 90 review, any further treatment need was evaluated 
by a Specialist in Periodontology.
2.3 | Systemic inflammatory markers
Systemic inflammatory markers CRP (primary outcome), IL-6 and 
TNFα (secondary outcomes) were measured at all timepoints 
(baseline, day 1, day 7 and day 90). Levels of serum CRP were 
determined by high-sensitivity immunoturbidometry using the 
Cobas C311 analyser (Cobas; Roche Diagnostic). Serum IL-6 and 
TNFα were determined using high-sensitivity ProQuantum qPCR 
immunoassays (Thermo Fisher) measured on a StepOnePlus real-
time PCR system. The limit of detection (LOD) for IL-6 and TNFα 
was 0.12 and 0.01 pg/ml, respectively. CRP and IL-6 were detected 
in all samples; TNFα was below LOD in seven samples which were 
assigned as LOD/2 for statistical analysis. All laboratory assays 
were conducted following study completion by laboratory staff 
masked to treatment groups. Analysis of serum CRP was per-
formed at the British Heart Foundation Glasgow Cardiovascular 
Research Centre, with IL-6 and TNFα measurements performed 
at Glasgow Dental School. Intra- and inter-assay coefficients of 
variations were <5%.
2.4 | Sample size calculation
The primary outcome for this study was serum CRP levels at day 1 
post-treatment. Secondary outcomes were CRP at day 7 and day 
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90, other systemic inflammatory markers (IL-6, TNFα) at day 1, day 
7 and day 90, clinical parameters at day 90 and treatment time. The 
sample size calculation was based on data from a previous study that 
measured changes in CRP following periodontal treatment (Graziani 
et al., 2015). From this study, a difference of 3.5 mg/L (SD = 3 mg/L) 
in CRP was detected between the two groups receiving different 
schedules of periodontal treatment (quadrant versus full-mouth 
debridement) at primary endpoint, and this has been considered 
F I G U R E  1   CONSORT flow diagram for study. Blood samples were not obtained from one patient at day 1 (UI group), one patient at day 7 
(HI group) and one patient at day 90 (UI group). Therefore, for analysis of serum inflammatory markers; at day 1 (UI; n = 17, HI; n = 19), day 7 
(UI; n = 18, HI; n = 18) and day 90 (UI; n = 17, HI; n = 19). For analysis of clinical parameters and treatment time (UI; n = 18, HI; n = 19)
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clinically relevant in recent guidelines (Sanz et al., 2020); therefore, 
this was considered a reasonable estimate of the minimum clinically 
relevant difference. At 80% power and a 5% significance level, a 
sample size of n = 34 (17 in each group) was required to detect a 
minimum difference of at least 1 standard deviation between CRP 
levels at primary endpoint (day 1) between the two groups (HI ver-
sus UI). To account for potential drop-out of 20%, 42 eligible pa-
tients were recruited.
2.5 | Statistical analysis
Study data were entered into SPSS (v26; IBM) using anonymous 
patient codes and then analysed using Stata (v21; Statacorp). 
Graphics were produced using PRISM (v8; GraphPad). All outcome 
data are summarized using median (Q1, Q3). Changes in clinical 
parameters and serum inflammatory markers between baseline 
and the various follow-ups were assessed using Wilcoxon signed 
rank tests. For between-group comparisons, general linear models 
(GLMs) were produced. Serum CRP, IL-6 and TNFα were skewed 
on visual inspection of histograms; therefore these were ln-trans-
formed and shown to follow a ln-normal (symmetrical) distribution. 
GLMs were produced to test differences in systemic inflammatory 
markers (CRP, IL-6 and TNFα all ln-transformed) between the two 
groups (HI; US), unadjusted (model 1), after adjusting for baseline 
levels (model 2), and after adjusting for baseline levels, gender, age, 
smoking status and BMI (model 3). Differences in clinical parame-
ters between groups at day 90 were assessed using GLMs adjusting 
for baseline levels, number of teeth, age, gender and smoking sta-
tus. For skewed variables (FMPS, FMBS, Pockets ≥5 mm and PISA), 
ln-transformation resulted in normal distribution and these values 
were used. Differences in treatment time were assessed by a GLM 
controlling for disease severity (PISA mm2) and number of teeth at 
baseline. Correlations between treatment time and disease sever-
ity (PISA mm2) and change in inflammatory markers (day 1 minus 
baseline values) were conducted using Spearman's Rho. The corre-
lations were ancillary post hoc analyses and were not pre-specified 
in the trial protocol.
3  | RESULTS
3.1 | Study population and clinical parameters
In total, 42 patients were recruited to the study. Throughout the 
course of the study, four subjects were excluded. One patient was 
withdrawn due to developing new medical diagnoses following 
baseline visit and two patients were withdrawn due to unexplained 
repeated fainting during venepuncture. One patient completed all 
interventions but was excluded from analysis due to an unexplained 
pathologically high baseline serum CRP level (11.97 mg/L), as shown 
in Figure 1.
Baseline characteristics were comparable between treatment 
groups, including demographic, clinical and biological variables 
(Table 1). According to the 2017 Classification, 45% of the patients 
presented with Generalized Stage 4 Grade C periodontitis, 42% with 
Generalized Stage 3 Grade B periodontitis and 13% Generalized 
Stage 3 Grade C periodontitis (Papapanou et al., 2018).
There were significant improvements in clinical parameters 
across all patients following treatment (p < .01 for all clinical param-
eters comparing baseline and day 90 values, irrespective of treat-
ment group). This included reductions in the percentage of pockets 
≥5 mm (HI: 28.85%–11.67%, UI: 26.73%–10.88%) and PISA (HI: 
1010.02–192.59 mm2, UI: 957.93–134.85 mm2). The improvement 
in clinical parameters was comparable between treatment groups 
(p > .05 for all; Table 2).
TA B L E  1   Baseline demographics and periodontal clinical 
parameters
Variable
Ultrasonic instruments
(n = 18)
Hand 
instruments
(n = 19)
Age, years 46.00 (36.75, 54.50) 41.00 (39.00, 
49.00)
Gender, female (%)† 10 (56) 9 (47)
Smoking, current 
(%)†
5 (28) 6 (32)
BMI, kg/m2 27.80 (22.68, 30.15) 29.70 (23.30, 
34.40)
Systolic BP, mm Hg 124.00 (114.50, 
139.50)
123.00 (117.00, 
134.00)
Diastolic BP, mm Hg 79.50 (75.50, 89.00) 81.00 (73.00, 
84.00)
CRP, mg/L 1.60 (0.62, 2.49) 1.21 (0.44, 2.03)
IL-6, pg/ml 2.61 (1.13, 3.54) 2.29 (1.52, 4.41)
TNFα, pg/ml 0.22 (0.11, 1.09) 0.13 (0.09, 0.36)
Number of teeth 27.50 (24.50, 30.00) 29.00 (27.00, 
31.00)
FMPS (%) 45.92 (26.10, 63.33) 60.48 (25.00, 
67.74)
FMBS (%) 38.11 (21.45, 61.49) 45.00 (21.26, 
69.44)
PPD (mm) 3.70 (3.35, 4.12) 3.98 (3.11, 4.78)
CAL (mm) 4.14 (3.66, 4.44) 4.36 (3.29, 5.02)
Pockets ≥5 mm (%) 26.73 (22.08, 36.71) 28.85 (18.33, 
51.39)
PISA (mm2) 957.93 (385.55, 
1,759.57)
1,010.02 
(561.99, 
2,190.01)
Note: Variables are presented as median (Q1, Q3), unless followed by “†” 
which are presented as n (%).
Abbreviations: BMI, body mass index; BP, blood pressure; CAL, clinical 
attachment loss; CRP, C-reactive protein; FMBS, full-mouth bleeding 
score; FMPS, full-mouth plaque score; IL-6, interleukin-6; PISA, 
periodontal inflamed surface area; PPD, probing pocket depth; TNFα, 
tumour necrosis factor alpha.
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3.2 | Systemic inflammation
When combining all patients, there were significant increases in the 
levels of serum CRP at day 1 (p = .002 day 1 versus baseline) which re-
turned to baseline levels at day 7 (p = .215 day 7 versus baseline) and 
day 90 (p = .255 day 90 versus baseline; Figure 2a). Similarly, levels 
of serum IL-6 in all patients increased at day 1 (p = .019 day 1 versus 
baseline) and returned to baseline levels at day 7 (p = .765 day 7 ver-
sus baseline) and day 90 (p = .671 day 90 versus baseline; Figure 2b). 
There were low levels of serum TNFα in the majority of patients, with 
seven samples below the assay detection limit. Serum TNFα was sig-
nificantly reduced at day 1 (p = .002 versus baseline). Interestingly, 
TNFα returned to baseline levels at day 7 (p = .765 versus baseline) but 
reduced again at day 90 (p = .013 versus baseline; Figure 2c).
Variable Timepoint
Ultrasonic 
instruments
n = 18
Hand 
instruments
n = 19
Between group 
p-valueb 
FMPS (%) Baseline 45.92 (26.10, 
63.33)
60.48 (25.00, 
67.74)
Day 90 7.80 (3.50, 
13.25)
8.33 (4.17, 
14.06)
Within group 
p-valuea 
<.001 <.001 .55
FMBS (%) Baseline 38.11 (21.45, 
61.49)
45.00 (21.26, 
69.44)
Day 90 8.10 (4.12, 
12.08)
8.33 (2.98, 
13.10)
Within group 
p-valuea 
<.001 <.001 .94
Pockets ≥5 mm (%) Baseline 26.73 (22.08, 
36.71)
28.85 (18.33, 
51.39)
Day 90 10.88 (3.87, 
16.88)
11.67 (3.89, 
30.95)
Within group 
p-valuea 
<.001 <.001 .23
PISA (mm2) Baseline 957.93 
(385.55, 
1,759.57)
1,010.02 
(561.99, 
2,190.01)
Day 90 134.85 (62.31, 
219.72)
192.59 (59.78, 
380.49)
Within group 
p-valuea 
<.001 <.001 .68
PPD (mm) Baseline 3.70 (3.35, 
4.12)
3.98 (3.11, 
4.78)
Day 90 2.68 (2.39, 
3.09)
3.02 (2.52, 
3.73)
Within group 
p-valuea 
<.001 <.001 .08
CAL (mm) Baseline 4.14 (3.66, 
4.44)
4.36 (3.29, 
5.02)
Day 90 3.64 (3.10, 
4.12)
4.01 (3.03, 
4.68)
Within group 
p-valuea 
<.001 .005 .14
Note: Values are presented as median (Q1, Q3).
aDifferences between baseline and day 90 within groups tested using Wilcoxon signed rank test. 
bGLMs were used to test differences in clinical parameters between the groups at day 90 having 
adjusted for baseline levels, number of teeth, age, gender and smoking status. For skewed variables 
(FMPS, FMBS, Pockets ≥5 mm and PISA) ln-transformed values were used. 
TA B L E  2   Comparison of clinical 
parameters between groups at baseline 
(BL) and day 90 (D90)
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The differences between treatment groups for serum inflam-
matory markers at day 1 (primary outcome), day 7 and day 90 
were then investigated using a GLM controlling for baseline lev-
els of each marker, smoking status, age, gender and BMI (Table 3). 
Despite significant increases in serum CRP at day 1, there were 
no statistically significant differences between treatment groups 
(p(adjusted) = .22). This remained consistent for CRP levels at day 
7 (p(adjusted) = .53) and day 90 (p(adjusted) = .28). Similarly, there 
was no difference in levels of serum IL-6 and TNFα between treat-
ment groups at day 1, day 7 and day 90 (p > .05 for both cytokines 
at all timepoints).
3.3 | Treatment time
We next sought to assess differences in treatment time between 
HI and UI groups. For total treatment time, the mean (SD) for UI 
was 75.39 (17.83) min, compared with 96.90 (23.54) min for HI 
(Figure 3a). The difference in treatment time between instruments 
(UI-HI) was assessed using a GLM controlling for disease sever-
ity (PISA mm2) and number of teeth at baseline (β: −22.12, 95% CI: 
−35.19 to −9.06, p = .002). Following post hoc analysis, there was no 
correlation between treatment time and disease severity at baseline 
(PISA mm2) for UI (Spearman r = .152, p = .547; Figure 3b), whilst 
there was a positive correlation for HI (Spearman r = .598, p = .007; 
Figure 3c). We found no significant positive or negative correlation 
between the change in serum inflammatory markers (day 1 minus 
baseline values) and the time of treatment (Figure 3d,f).
4  | DISCUSSION
To the authors' knowledge, this is the first randomized controlled 
trial to investigate the impact of different periodontal instrumen-
tation techniques on systemic inflammation following full-mouth 
debridement. As expected, a significant increase in CRP was ob-
served one day following treatment across all patients; however, 
the level of CRP at day 1 did not differ following hand or ultrasonic 
instrumentation.
The observed short-term CRP increase is consistent with previ-
ous studies conducted with similar inclusion and exclusion criteria 
(D'Aiuto, Nibali, Mohamed-Ali, Vallance, & Tonetti, 2004; Graziani 
et al., 2015; Graziani et al., 2010; Morozumi et al., 2018; Tonetti et al., 
2007). However, the average magnitude of the increase in immedi-
ate post-treatment CRP was 1.67-fold in this study; somewhat less 
than that reported in previous studies (Graziani et al., 2015; Tonetti 
et al., 2007), which showed an approximately 3-fold and 8-fold in-
crease in CRP 24-hr post-treatment respectively. An explanation 
for this may lie in the differential in mean treatment times between 
studies (Graziani et al., 2015; Tonetti et al., 2007). Mean treatment 
time for all patients in this study was 86.8 ± 23.5 min, which was less 
than Graziani et al. where the reported mean treatment time was 
123 ± 18 min for their full-mouth debridement group. Similarly, the 
mean baseline plaque score for this study was 44.68 ± 25.68% (UI 
group) whereas Graziani et al. reported 70 ± 26% in their full-mouth 
debridement group. This difference may be due to patients in this 
study having received basic oral hygiene instruction prior to refer-
ral to the department. Furthermore, study patients received a full-
mouth supragingival scale prior to treatment (Lang & Lindhe, 2015; 
Scottish Dental Clinical Effectiveness Programme 2014; Suvan et al., 
2019) (following baseline plaque scoring), which will likely have re-
duced plaque scores even further prior to full-mouth debridement. 
These factors may help explain relative differences in mean treat-
ment time or CRP response between studies.
A recently released joint consensus statement between the 
European Federation of Periodontology and American Academy 
F I G U R E  2   Levels of serum inflammatory markers in patients 
treated with ultrasonic (grey boxes) and hand instruments (clear 
boxes) at baseline, day 1, day 7 and day 90 follow-up. (a) CRP (b) 
IL-6 and (c) TNFα. Data are displayed as a Tukey boxplot, where 
the median is represented by the central horizontal line and mean 
displayed as “+”. As described previously, day 1: UI; n = 17 HI; 
n = 19, day 7: UI; n = 18 HI; n = 18, day 90: UI; n = 17 HI; n = 19. 
For statistical analysis, see Table 3
Baseline Day 1 Day 7 Day 90
0
2
4
6
8
10
20
30
C
R
P 
(m
g/
L)
Ultrasonic
Hand
Baseline Day 1 Day 7 Day 90
0
4
8
12
15
25
IL
-6
 (p
g/
m
L)
Ultrasonic
Hand
Baseline Day 1 Day 7 Day 90
0.0
0.5
1.0
1.5
2.0
TN
F
 (p
g/
m
L)
Ultrasonic
Hand
(a)
(b)
(c)
1094  |     JOHNSTON eT al.
of Periodontology advised against the use of full-mouth debride-
ment in patients with any level of cardiovascular disease (Sanz et al., 
2020). In this study, an increase in serum CRP was observed across 
all patients (average increase of 1.07 mg/L), although we observed 
heterogeneity in the extent of this response. The absolute change 
in serum CRP from baseline to day 1 ranged from a 3.45 mg/L 
decrease to a 17.56 mg/L increase, suggesting large inter-patient 
variation, which did not relate to instrumentation choice. Therefore, 
establishing whether demographic, clinical or biological factors at 
baseline influence or predict this response is important in order to 
establish which patients may be more at risk of a significant CRP 
spike. As noted, there are differences in plaque indexes between 
TA B L E  3   Parameter estimates with 95% confidence intervals for ultrasonic instrumentation compared with hand instrumentation for ln-
transformed serum CRP, IL-6 and TNFα levels at day 1, day 7 and day 90
Day 1 Day 7 Day 90
β 95% CI
p-
Value β 95% CI
p-
Value β 95% CI
p-
Value
C-reactive protein
Model 1a  0.143 −0.582 to 0.867 .69 −0.271 −1.094 to 0.553 .51 −0.518 −1.239 to 0.202 .15
Model 2b  0.130 −0.369 to 0.628 .60 −0.311 −0.950 to 0.329 .33 −0.482 −1.038 to 0.073 .09
Model 3c  0.318 −0.196 to 0.832 .22 −0.231 −0.972 to 0.510 .53 −0.304 −0.867 to 0.259 .28
Interleukin-6
Model 1a  0.133 −0.378 to 0.643 .60 0.176 −0.620 to 0.972 .66 −0.011 −0.671 to 0.650 .97
Model 2b  0.261 −0.093 to 0.614 .14 0.233 −0.524 to 0.991 .54 0.053 −0.546 to 0.653 .86
Model 3c  0.193 −0.173 to 0.559 .29 0.182 −0.634 to 0.999 .65 −0.005 −0.645 to 0.636 .99
Tumour necrosis factor α
Model 1a  0.607 −0.307 to 1.521 .19 0.189 −0.568 to 0.946 .62 0.49 −0.192 to 1.171 .15
Model 2b  0.00003 −0.677 to 0.678 .99 −0.087 −0.843 to 0.669 .82 0.021 −0.512 to 0.555 .94
Model 3c  −0.215 −0.902 to 0.472 .53 −0.167 −1.022 to 0.688 .69 −0.121 −0.687 to 0.445 .67
Note: Parameter estimates (β-values) are based on ln-transformed data.
As described in Figure 1, day 1: UI; n = 17 HI; n = 19, day 7: UI; n = 18 HI; n = 18, day 90: UI; n = 17 HI; n = 19.
aModel 1: Unadjusted. 
bModel 2: Adjusted for baseline levels of each serum marker. 
cModel 3: Adjusted for baseline levels of serum marker, gender, age, smoking status and BMI at baseline. 
F I G U R E  3   Treatment time comparison 
between ultrasonic (n = 18) and hand 
(n = 19) instrumentation. (a) Total 
treatment time controlled for number of 
teeth and disease severity (PISA mm2) 
at baseline, **p < .01, GLM. Correlation 
between total treatment time with (b) 
ultrasonic instruments and (c) hand 
instruments versus disease severity. 
Correlations between the change (Δ) in 
serum CRP (d), IL-6 (e) and TNFα (f) and 
treatment time. Grey circles represent 
patients in ultrasonic treatment group, 
white represent hand treatment group. All 
correlations are Spearman-rho, **p < .01, 
ns indicates no significant difference. UI; 
n = 18, HI; n = 19
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our study and those conducted previously. Thus, assessing whether 
supragingival debridement, prior to full-mouth debridement, may 
help reduce this spike would be an important addition to future 
research.
In this study, with respect to long-term changes in CRP, at day 90 
follow-up serum CRP was similar to baseline levels. There were no 
changes in serum IL-6, although a reduction was found in TNFα at 
day 90 compared with baseline. However, the significance of this is 
questionable given that only very low levels of TNFα were detected 
at all time points. In relation to CRP and IL-6, 90-days following 
treatment may be too early to detect a net reduction in these circu-
lating inflammatory markers. Moreover, the current study was not 
powered to detect this long-term difference. Some studies report 
a significant decrease in serum CRP (and IL-6) following intensive 
periodontal therapy at a follow-up of 2 months (D'Aiuto, Nibali, 
Parkar, Suvan, & Tonetti, 2005), whilst others report no change 
after 6 weeks (Ide et al., 2003). One explanation for these contrast-
ing results may be patient comorbidities. A previous systematic 
review concluded that patients with comorbidities demonstrate 
significantly greater reductions in CRP following NSPT compared 
with systemically healthy patients (Teeuw et al., 2014). As the pa-
tients in the current study were systemically healthy and did not 
display elevated CRP levels (43% patients <1 mg/L, 41% patients 
1–3 mg/L, 16% patients >3 mg/L at baseline), it is perhaps unsur-
prising that there was no notable reduction in serum CRP following 
treatment.
There were no discernible differences in clinical outcome, com-
paring instrumentation techniques, albeit this finding should be 
viewed as a secondary outcome measure that the study was not 
powered to investigate. Encouragingly, all patients' clinical param-
eters showed marked improvement following therapy. A pocket 
closure rate (defined as conversion of a periodontal site measuring 
≥5 mm to a site measuring ≤4 mm) of 58.54%, mean periodontal 
probing depth reduction of 0.98 mm and mean PISA reduction of 
985.92 mm2 (80.83% reduction) was recorded on average across all 
patients at day 90. These findings are similar to a recent rigorous 
systematic review that identified pocket closure rates of 57% and 
mean periodontal probing depth reductions of 1.0 mm at 3/4 month 
follow-up (Suvan et al., 2019).
The reduced treatment time for use of ultrasonic compared with 
hand instruments is commensurate with previous studies (Badersten, 
Nilveus, & Egelberg, 1981; Breininger, O'Leary, & Blumenshine, 1987; 
Dragoo, 1992; Laurell, 1990; Tunkel et al., 2002; Yukna et al., 1997). 
Interestingly, treatment time for hand instrumentation correlated 
with disease severity, whist ultrasonic showed no such relationship; 
it could be speculated that ultrasonics may offer greater time saving 
for the treatment of severe PD. However, it should be noted that this 
is an incidental finding of this study and confirmation would require 
more rigorous investigation.
The current study was designed from the outset to investigate 
CRP levels at day 1 following two methods of periodontal instru-
mentation. Robust randomization, concealed allocation and appro-
priate blinding were implemented. Inevitably, potential for bias and 
limitations remain in certain aspects of this clinical trial. For example, 
there may be uneven distribution of unidentified confounding vari-
ables between interventional arms. Inclusion of factors such as BMI 
and baseline CRP in stratification techniques could be considered 
for future studies. In addition, patients with good motivation and 
compliance with dental care may self-select for inclusion within trials 
and this has implications for external validity as patients within the 
larger population may not adhere to oral hygiene instruction to the 
same extent—thus influencing their periodontal disease outcome. In 
this study, it was impossible to blind operators to treatment modality 
which may potentially result in observation bias. The current study 
found equivalence between the groups in terms of the primary out-
come measure of change in CRP post-treatment. The findings from 
the current study can be considered robust; however, the study was 
designed to detect a meaningful difference, and not designed to de-
tect equivalence, thus the data should be interpreted with due con-
sideration to this caveat.
In conclusion, the data presented show that systemic inflamma-
tion, as measured by serum CRP, showed a significant increase 1-day 
following full-mouth debridement. There was no difference in CRP 
at day 1 between hand instrumentation and ultrasonic instrumenta-
tion techniques. Treatment efficacy was similar in both groups; how-
ever, treatment was significantly quicker with ultrasonic instruments 
regardless of disease severity.
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